Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans

Psychopharmacology

Volumn 143, Issue 1, 1999, Pages 102-110

  Haney, Margaret ^a   Collins, Eric D ^a   Ward, Amie S ^a   Foltin, Richard W ^a   Fischman, Marian W ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Cardiovascular effect; Cocaine; Craving; D1 agonist; Human; Self administration; Subjective effect

Indexed keywords

ADROGOLIDE; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR;

ADULT; ARTICLE; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; REINFORCEMENT; WITHDRAWAL SYNDROME;

ADMINISTRATION, INHALATION; ADULT; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; PRODRUGS; PYRIDINES; SELF ADMINISTRATION; TETRAHYDRONAPHTHALENES;

EID: 0032900595     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050925     Document Type: Article

References (39)

1. Arndt IO, McLellan TA, Dorozynsky L, Woody GE, O'Brien CP (1994) Desipramine treatment for cocaine dependence. Role of antisocial personality disorder. J Nerv Ment Dis 182:151-156
2. Beninger RJ, Ranaldi R (1992) The effects of amphetamine, apomorphine, SKF 38393, quinpirole and bromocriptine on responding for conditioned reward in rats. Behav Pharmacol 3:155-163
3. 1-like receptor agonists impair responding for conditioned reward in rats. Behav Pharmacol 6:785-793
4. Caine SB, Koob GF (1993) Modulation of cocaine self-administration in the rat through D-3 dopamine receptor. Science 260:1814-1816
5. 3 receptor test in vitro predict decreased cocaine self-administration in rats. Neuropharmacol Neurotoxicol 8:2373-2377
6. 2 dopamine agonists on cocaine discrimination and self-administration in rats. Soc Neurosci Abstr 23:1103
7. Davis MW, Smith SG (1977) Catecholaminergic mechanisms of reinforcement: direct assessment by drug self-administration. Life Sci 20:483-492
8. Dwoskin LP, Peris J, Yasuda RP, Philpott K, Zahniser NR (1988) Repeated cocaine administration results in supersensitivity of striatal D-2 dopamine autoreceptors to pergolide. Life Sci 42:255-262
9. Fibiger HC (1978) Drugs and reinforcement mechanisms: a critical review of the catecholamine theory. Annu Rev Pharmacol Toxicol 18:37-56
10. Fischman MW, Foltin RW, Nestadt G, Pearlson GD (1990) Effects of desipramine maintenance on cocaine self administration by humans. J Pharmacol Exp Ther 253:760-770
11. Foltin RW, Fischman MW, Nestadt G, Stromberger H, Cornell EE, Pearlson GD (1990) Demonstration of naturalistic methods for cocaine smoking by human volunteers. Drug Alcohol Depend 26:145-154
12. 2 receptors. Life Sci 49:925-930
13. 1 receptor agonists by squirrel monkeys. Psychopharmacology 125:97-104
14. Haney M, Fischman MW, Foltin RW (1998) Effects of pergolide on cocaine self-administration in men and women. Psychopharmacology 137:15-24
15. Jackson DM, Westlind-Danielsson A (1994) Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmacol Ther 64:291-369
16. Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93-96
17. Keppel G (1991) Design and analysis: a researcher's handbook. Prentice Hall, Englewood Cliffs, N.J.
18. Kleber HD (1995) Pharmacotherapy, current and potential, for the treatment of cocaine dependence. Clin Neuropharmacol 18:S96-S109
19. Levin FR, McDowell D, Evans SM, Brooks D, Spano C, Nunes EV (1999) Pergolide mesylate for cocaine abuse: a controlled preliminary trial. Am J Addict (in press)
20. Little RJA, Rubin DB (1987) Statistical analysis with missing data. Wiley, New York
21. Malcolm R, Brady K, Moore J, Sutherland S (1999) Dose response effects of pergolide in the treatment of cocaine dependence. NIDA Res Monogr Series (in press)
22. 1 receptor agonist ABT-431 reduces cocaine-induced craving in human cocaine abusers. NIDA Res Monogr Series (in press)
23. Mendelson JH, Mello NK (1996) Management of cocaine abuse and dependence. N Engl J Med 334:965-972
24. 3 receptor stimulation enhances cocaine reinforcement. J Neurochem 67:1078-1089
25. Preston KL, Sullivan JT, Strain EC, Bigelow GE (1992) Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers. J Pharmacol Exp Ther 262:279-291
26. Rubin DB, Schenker N (1991) Multiple imputation in health-care data bases: an overview and some applications. Statist Med 10:585-598
27. 1 agonists SKF 82958 and SKF 77434 are self-administered by rats. Brain Res 582:349-352
28. 2-like dopamine receptor agonists. Science 271:1586-1589
29. 2, receptors. Psychopharmacology 123:303-306
30. 1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease. J Pharmacol Exp Ther 276:150-160
31. Spealman RD, Bergman J, Madras BK, Melia KF (1991) Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes. J Pharmacol Exp Ther 258:945-953
32. 1 agonists. Psychopharmacology 133:283-292
33. Tennant FS, Sagherian AA (1987) Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. Arch Int Med 147:109-112
34. 1 agonists in rhesus monkeys. J Pharmacol Exp Ther 275:1367-1374
35. 1 agonists in monkeys. J Pharmacol Exp Ther 283:29-38
36. 1 dopamine agonist SKF 81297 in rhesus monkeys. Psychopharmacology 113:51-52
37. Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492
38. Wise RA, Murray A, Bozarth MA (1990) Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats. Psychopharmacology 100:355-360
39. Woolverton WL, Goldberg LI, Ginos JZ (1984) Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J Pharmacol Exp Ther 230:678-683